Related Experiment Video
Updated: Jan 1, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells
Jun-Li Deng1,2, Rui Zhang1,2, Ying Zeng1,2
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, People's Republic of China.
Background:
In recent years, statins have been frequently investigated in neoplasms. However, the potential roles of statins on prostate cancer cells and the underlying mechanisms have not been fully elucidated. In current study, we explored the effect and molecular mechanism of statins on cell proliferation and apoptosis in prostate cancer cells.
Methods:
Prostate cancer cell were treated with gradient doses of simvastatin and fluvastatin for 24-72 h. Cell proliferation was analyzed by using MTS assay and colony formation. Cell apoptosis was measured by Hoechst staining, flow cytometry and caspase-3 activity. Western blotting was used to evaluate the proteins levels.
Results:
Both simvastatin and fluvastatin produced a dose- and time-dependent inhibition of cell viability and colony formation while a promotion of cell apoptosis as evident with increases in caspase-3 activity, cleaved-caspase-3, cleaved-caspase-8 and cleaved-PARP levels in PC3 cells. Similar statin effects were observed in DU145 prostate cancer cells. Furthermore, statins produced a time- and dose-dependent reduction of phosphorylated-AKT and phosphorylated-FOXO1 levels in PC3 cells, and pretreatment of cells with an AKT phosphorylation inhibitor, MK2206, potentiated statins' effect.
Conclusion:
Statins decrease cell proliferation and induce cell apoptosis, probably mediated via a downregulation of AKT/FOXO1 phosphorylation in prostate cancer cells, which may have a potential benefit in prostate cancer prevention and therapy.
Insights
Statins like simvastatin and fluvastatin inhibit prostate cancer cell growth and promote apoptosis. This effect is linked to the downregulation of AKT/FOXO1 phosphorylation, suggesting a role in cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Statins are increasingly studied for their role in neoplasms.
- The precise mechanisms of statins in prostate cancer remain unclear.
Purpose of the Study:
- To investigate the effects of statins on prostate cancer cell proliferation and apoptosis.
- To elucidate the underlying molecular mechanisms of statin action in prostate cancer.
Main Methods:
- Prostate cancer cells (PC3, DU145) were treated with simvastatin and fluvastatin.
- Cell proliferation assessed via MTS assay and colony formation.
- Apoptosis evaluated using Hoechst staining, flow cytometry, and caspase-3 activity; protein levels determined by Western blotting.
Main Results:
- Simvastatin and fluvastatin dose-dependently inhibited cell viability and colony formation.
- Statins promoted apoptosis, indicated by increased caspase-3 activity and cleaved protein levels.
- Statin treatment reduced phosphorylated-AKT and phosphorylated-FOXO1, with an AKT inhibitor potentiating these effects.
Conclusions:
- Statins reduce prostate cancer cell proliferation and induce apoptosis.
- The mechanism involves downregulation of AKT/FOXO1 phosphorylation.
- Statins show potential for prostate cancer prevention and therapy.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Related Concept Videos
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway